Podcasts

Episode 53 | A/Prof Bryan Chan: Lessons from Fellowships and building Clinical Trials Units

In this episode, we welcome A/Prof Bryan Chan, a senior Medical Oncologist and this years TOGA ASM Convener.

Episode Summary

Bryan, affiliated with multiple institutions including Adam Crosby Cancer Center and Griffith University, discusses his comprehensive career journey from fellowship at the Princess Margaret Cancer Center in Toronto to his current roles in Australia. The discussion highlights the benefits of overseas fellowships, the development of clinical trials, and his leadership in thoracic oncology at the Sunshine Coast University Hospital. Bryan also touches upon the challenges and rewards of balancing private and public practice and pioneering quality improvement initiatives. The episode concludes with an exciting preview of the upcoming TOGA Annual Scientific Meeting, which Bryan is convening. Medical professionals and anyone interested in the latest in lung cancer research and practice will find valuable insights in this conversation with Bryan. 

 Show Guest

  • A/Prof Bryan Chan, Senior Medical Oncologist, Sunshine Coast University Hospital, Associate Professor, Griffith University, Adjunct Associate Professor, University of the Sunshine Coast and University of Queensland.
Listen to a lung cancer podcast with Bryan Chan

Play Episode 53 | A/Prof Bryan Chan: Lessons from Fellowships and building Clinical Trials Units

More Podcasts

Host A/Prof Steven Kao is joined by A/Prof Venessa Chin and Dr Ben Kong,
Host A/Prof Mel Moore interviews Prof Zarnie Lwin OAM, University of Queensland; Medical Oncologist at Royal Brisbane and Women’s Hospital and The Prince Charles Hospital.
A/Prof Gavin Wright sits down with a multidisciplinary panel of experts to tackle the critical and complex issue of smoking-related stigma in lung cancer.
Host A/Prof Mel Moore interviews Dr Jazmin Eckhaus, a practising surgeon in the subspecialty of thoracic surgery.
Host A/Prof Adnan Nagrial leads a panel discussing the clinical implications of the broad PBS listing of ipilimumab and nivolumab in Australia.
Host A/Prof Deme Karikios leads a panel discussion focusing on the recent, groundbreaking broad PBS listing of certain immunotherapy agents in Australia.